For comments, suggestions
Created with Raphaël 2.1.0 28.07.2016 Filing date 26.02.2018 Validation fee payment 31.07.2018 (A1) Patent application published 04.11.2021 AGEPI application filing date 31.01.2022 (T2) Translation of the validated European patent 21.06.2026 28.07.2026 Valid until 29.07.2027 Renewal fee to be paid until 28.07.2036 Patent will expire on

Patent in force


(210)Number of the EPO application16831339
(220)Filing date of the EPO application2016.07.28
(80)EPO patent specification publication (B)EPB nr. 34/2021, 2021.08.25
(110)EPO patent number3328419
(11)Number of the documentMD 3328419 T2
(21)Number of the applicatione 2018 0572
(71)Name(s) of applicant(s), code of the countryMACROGENICS INC., US;
(72)Name(s) of inventor(s), code of the countrySHAH Kalpana, US;
SMITH Douglas H., US;
LA MOTTE-MOHS Ross, US;
JOHNSON Leslie S., US;
MOORE Paul A., US;
BONVINI Ezio, US;
KOENIG Scott, US;
(73)Name(s) of owner(s), code of the countryMACROGENICS INC., US;
(54)Title of the inventionPd-1-binding molecules and methods of use thereof
(13)Kind-of-document code T2
(51)International Patent Classification A61K 39/00 (2006.01.01); A61K 39/395 (2006.01.01); C07K 16/28 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2018.07.31
(49)Date of publication of the translation of the validated European patent specification2022.01.31
(30)Priority201562198867 P, 2015.07.30, US; 201562239559 P, 2015.10.09, US; 201562255140 P, 2015.11.13, US; 201662322974 P, 2016.04.15, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/US2016/044430, 2016.07.28
(87)International publicationWO 2017/019846, 2017.02.02
Up
/Inventions/details/3328419